NEW YORK (GenomeWeb News) - OPX Biotechnologies has received $3.6 million in its second round of venture financing, which was led by Mohr Davidow Ventures.
 
Other investors in the round included X/Seed Capital, which provided OPX’s seed financing in June 2007, and Robert Chess, who has been named OPX CEO and chairman.
 
Boulder, Colo.-based OPX is developing genomics technologies designed for microbial biofuel development.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.